February 14, 2025
The article introduces NanoCas, a miniaturized version of the CRISPR-Cas9 gene editing tool developed by Mammoth Biosciences. NanoCas reduces the size of the Cas9 component to about one-third of its original size, enabling it to be delivered more effectively to various tissues in the body. This advancement addresses the delivery challenges of traditional CRISPR systems,…